Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2
AssigneeAcorda Therapeutics, Inc.
InventorMark Marchionni
Life of this patent
Estimating the term…
Abstract
The invention features methods of treatment and diagnosis using NRG-2 polypeptides, nucleic acid molecules, and antibodies. The invention also provides novel NRG-2 polypeptides and nucleic acid molecules.
Claims9
A method of increasing the cardiomyocyte survival, cardiomyocyte proliferation, cardiomyocyte growth, or cardiomyocyte differentiation in a mammal in need thereof, said method comprising administering a neuregulin 2 (NRG-2) polypeptide to said mammal in an amount effective for increasing said cardiomyocyte survival, cardiomyocyte proliferation, cardiomyocyte growth, or cardiomyocyte differentiation, wherein the NRG-2 polypeptide comprises the amino acid sequence of SEQ ID NO:
- 4.
Dependencies are inferred from the claim text.